◆英語タイトル:Diffusion Pharmaceuticals Inc (DFFN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7962
◆発行会社(調査会社):
GlobalData
◆発行日:2018年10月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Diffusion Pharmaceuticals Inc (Diffusion), formerly Diffusion Pharmaceuticals LLC is a clinical stage biotechnology company that develops standard of care therapies. The company improves cancer treatments such as radiation therapy and chemotherapy in treatment-resistant solid tumors, including multiple FDA orphan-designated indications. It offers new and small-molecule drugs for regulating the movement of oxygen into tissue. Diffusion develops trans sodium crocetinate, a synthetic small molecule that improves the diffusion of oxygen into hypoxic tissue and sensitizes the tumor to radiation therapy. The company offers products for cancer, stroke and heart attack. It performs clinical study on pancreatic cancer and brain metastasis through cancer centers. Diffusion is headquartered in Charlottesville, Virginia, the US.
Diffusion Pharmaceuticals Inc (DFFN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Diffusion Pharma Raises USD3.4 Million in Venture Financing 10
Diffusion Pharma Raises US$10 Million In Venture Financing 11
Merger 12
RestorGenex Merges with Diffusion Pharma 12
Stratus Media Completes Merger With Canterbury Labs And Hygeia Therapeutics 13
Equity Offering 14
Diffusion Pharma Plans to Raise Funds through Public Offering of Shares 14
Diffusion Pharma Raises USD12 Million in Public Offering of Shares 15
Diffusion Pharma Plans to Raise Funds in Secondary Offering of Shares 17
Diffusion Pharma Raises USD9.2 Million in Second and Final Tranche of Private Placement of Series A Preferred Stock 18
Acquisition 20
Stratus Media Acquires Paloma Pharma 20
Diffusion Pharmaceuticals Inc – Key Competitors 21
Diffusion Pharmaceuticals Inc – Key Employees 22
Diffusion Pharmaceuticals Inc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Financial Announcements 24
Aug 13, 2018: Diffusion Pharmaceuticals reports second quarter 2018 financial results and provides business update 24
May 10, 2018: Diffusion Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update 25
Apr 03, 2018: Diffusion Pharmaceuticals Reports 2017 Financial Results and Provides Business Update 26
Nov 13, 2017: Diffusion Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update 27
Aug 14, 2017: Diffusion Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Business Update 29
May 15, 2017: Diffusion Pharmaceuticals Provides Corporate Highlights and Reports Financial First Quarter 2017 Results 31
Mar 31, 2017: Diffusion Pharmaceuticals Provides Corporate Highlights and Reports 2016 Financial Results 32
Corporate Communications 33
Aug 23, 2017: Diffusion Pharmaceuticals Names William Hornung Chief Business Officer 33
Jul 06, 2017: Diffusion Pharmaceuticals Appoints Dr. Robert Ruffolo to Board of Directors 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35
List of Tables
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Diffusion Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Diffusion Pharma Raises USD3.4 Million in Venture Financing 10
Diffusion Pharma Raises US$10 Million In Venture Financing 11
RestorGenex Merges with Diffusion Pharma 12
Stratus Media Completes Merger With Canterbury Labs And Hygeia Therapeutics 13
Diffusion Pharma Plans to Raise Funds through Public Offering of Shares 14
Diffusion Pharma Raises USD12 Million in Public Offering of Shares 15
Diffusion Pharma Plans to Raise Funds in Secondary Offering of Shares 17
Diffusion Pharma Raises USD9.2 Million in Second and Final Tranche of Private Placement of Series A Preferred Stock 18
Stratus Media Acquires Paloma Pharma 20
Diffusion Pharmaceuticals Inc, Key Competitors 21
Diffusion Pharmaceuticals Inc, Key Employees 22
Diffusion Pharmaceuticals Inc, Subsidiaries 23
List of Figures
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8